{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:40:47Z","timestamp":1775475647822,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gofs.2020.01.020","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:41:41Z","timestamp":1580229701000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF\u00a0\u2013\u00a0Fertilit\u00e9"],"prefix":"10.1016","volume":"48","author":[{"given":"J.","family":"Raad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grynberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Courbiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mathieu d\u2019Argent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gofs.2020.01.020_bib0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Dara\u00ef","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2020.01.020_bib0255","first-page":"4","article-title":"Mucinous tumors of the ovary: a review","volume":"24","author":"Hart","year":"2005","journal-title":"Int J Gynecol Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.020_bib0260","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/cncr.10935","article-title":"Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978\u20131998","volume":"95","author":"Mink","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.020_bib0265","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.23724","article-title":"Borderline ovarian tumors in Sweden 1960\u20132005: trends in incidence and age at diagnosis compared to ovarian cancer","volume":"123","author":"Sk\u00edrnisd\u00f3ttir","year":"2008","journal-title":"Int J Cancer"},{"issue":"20","key":"10.1016\/j.gofs.2020.01.020_bib0270","first-page":"5849","article-title":"Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones","volume":"48","author":"Harlow","year":"1988","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2017.01.002","article-title":"Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: a nationwide case-control study","volume":"144","author":"Rasmussen","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.020_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2004.10.009","article-title":"Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study","volume":"83","author":"Fauvet","year":"2005","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.020_bib0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2005.07.029","article-title":"Borderline tumours of the ovary and fertility","volume":"42","author":"Morice","year":"2006","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.020_bib0290","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.020_bib0295","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","article-title":"Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.020_bib0300","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.020_bib0305","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","article-title":"Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden","volume":"91","author":"Sanner","year":"2009","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.gofs.2020.01.020_bib0310","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.020_bib0315","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","article-title":"Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort","volume":"100","author":"Trabert","year":"2013","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.020_bib0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/humupd\/dms051","article-title":"Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer\u00a0\u2013\u00a0a systematic review and meta-analysis","volume":"19","author":"Siristatidis","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.020_bib0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/IGC.0b013e318277608b","article-title":"Meta-analysis on the possible association between in vitro fertilization and cancer risk","volume":"23","author":"Li","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"9190","key":"10.1016\/j.gofs.2020.01.020_bib0330","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in-vitro fertilisation","volume":"354","author":"Venn","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2020.01.020_bib0335","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1757-2215-7-51","article-title":"Fertility drugs, reproductive strategies and ovarian cancer risk","volume":"7","author":"Tomao","year":"2014","journal-title":"J Ovarian Res"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.020_bib0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/GCO.0000000000000370","article-title":"Use of fertility medications and cancer risk: a review and update","volume":"29","author":"Kroener","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.gofs.2020.01.020_bib0345","first-page":"8042","article-title":"Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors","volume":"22","author":"Del Pup","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.gofs.2020.01.020_bib0350","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"6","author":"Rizzuto","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.020_bib0355","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.fertnstert.2012.08.009","article-title":"Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antim\u00fcllerian hormone level modifications","volume":"98","author":"Somigliana","year":"2012","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.020_bib0360","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jog.12830","article-title":"Surgical excision of ovarian endometriomas: does it truly impair ovarian reserve? Long term anti-M\u00fcllerian hormone (AMH) changes after surgery","volume":"41","author":"Vignali","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.020_bib0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fertnstert.2018.03.015","article-title":"Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study","volume":"110","author":"Kasapoglu","year":"2018","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmy049","article-title":"Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis","volume":"25","author":"Younis","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.020_bib0375","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.rbmo.2011.07.014","article-title":"Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons","volume":"23","author":"Biacchiardi","year":"2011","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.020_bib0380","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/humrep\/der006","article-title":"The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis","volume":"26","author":"Hirokawa","year":"2011","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.gofs.2020.01.020_bib0385","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/humrep\/deu199","article-title":"The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis","volume":"29","author":"Muzii","year":"2014","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0390","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/humrep\/den398","article-title":"Management of endometriomas in women requiring IVF: to touch or not to touch","volume":"24","author":"Garcia-Velasco","year":"2009","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.020_bib0395","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajog.2016.03.045","article-title":"The impact of excision of benign nonendometriotic ovarian cysts on ovarian reserve: a systematic review","volume":"215","author":"Mohamed","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.020_bib0400","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/09513590.2016.1142523","article-title":"Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry","volume":"32","author":"Cagnacci","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2020.01.020_bib0405","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10397-016-0940-x","article-title":"Effect of salpingectomy, ovarian cystectomy and unilateral salpingo-oopherectomy on ovarian reserve","volume":"13","author":"Rustamov","year":"2016","journal-title":"Gynecol Surg"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0410","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5468\/ogs.2017.60.3.289","article-title":"Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet Gynecol Sci"},{"issue":"9","key":"10.1016\/j.gofs.2020.01.020_bib0415","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/IGC.0000000000001092","article-title":"Prognostic factors for recurrence after fertility-preserving surgery in patients with borderline ovarian tumors: a systematic review and meta-analysis of observational studies","volume":"27","author":"Jiao","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.020_bib0420","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/dew137","article-title":"Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours","volume":"31","author":"Ouldamer","year":"2016","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.020_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.06.028","article-title":"Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors","volume":"211","author":"Bendifallah","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.020_bib0430","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/humrep\/deq159","article-title":"Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.gofs.2020.01.020_bib0435","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.020_bib0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/annonc\/mdp267","article-title":"Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary","volume":"21","author":"Uzan","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.020_bib0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.23942","article-title":"Fertility sparing surgery for localized ovarian cancers maintains an ability to conceive, but is associated with diminished reproductive potential","volume":"112","author":"Letourneau","year":"2015","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.020_bib0450","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/humrep\/det371","article-title":"Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours","volume":"28","author":"Uzan","year":"2013","journal-title":"Hum Reprod"},{"issue":"20","key":"10.1016\/j.gofs.2020.01.020_bib0455","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1200\/JCO.2007.10.8076","article-title":"Management of borderline ovarian neoplasms","volume":"25","author":"Cadron","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0460","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.fertnstert.2006.07.1503","article-title":"Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study","volume":"87","author":"Fortin","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2020.01.020_bib0465","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ctrv.2016.06.010","article-title":"Fertility preservation in women with borderline ovarian tumours","volume":"49","author":"Mangili","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.020_bib0470","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejca.2015.01.004","article-title":"Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk","volume":"51","author":"Vasconcelos","year":"2015","journal-title":"Eur J Cancer"},{"issue":"Suppl.","key":"10.1016\/j.gofs.2020.01.020_bib0475","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.3346\/jkms.2007.22.S.S134","article-title":"Outcomes of controlled ovarian hyperstimulation\/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment","volume":"22","author":"Park","year":"2007","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0480","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000316264","article-title":"Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery","volume":"70","author":"Denschlag","year":"2010","journal-title":"Gynecol Obstet Invest"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.020_bib0485","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1093\/humrep\/del301","article-title":"Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours","volume":"21","author":"Basille","year":"2006","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.020_bib0245","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bulcan.2017.10.032","article-title":"[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: guidelines from the French national network dedicated to rare gynaecological cancer]","volume":"105","author":"Rousset-Jablonski","year":"2018","journal-title":"Bull Cancer (Paris)"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:39:48Z","timestamp":1762853988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920300404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2468718920300404"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.020","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF\u00a0\u2013\u00a0Fertilit\u00e9","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}